Hydration Support for People Starting GLP-1 RA Therapy
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Recruiting
N/A
Interventional Study
Obesity & Overweight
Type 2 Diabetes
Type 2 Diabetes (Adult Onset)
Obesity Type 2 Diabetes Mellitus
Dehydration
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- State University of New York at Buffalo · Other
Who this trial is looking for
This trial is looking for adults aged 18-60 who have recently started a GLP-1 RA medication for type 2 diabetes. Participants will help test if increasing hydration can reduce side effects from the medication over 16 weeks.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult aged 18-60
- I have been prescribed a GLP-1 RA medication within the last week
- I can speak and understand English
- I am willing to follow the study guidelines
You may not be able to join if
- I am over 60 years old
- I am not taking a GLP-1 RA medication
- I have been on a GLP-1 RA for more than a week
- I am not fluent in English
- I am pregnant or plan to become pregnant during the study
- I am not willing to follow the study guidelines
- I have a cardiac implant
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side effects, and drug discontinuation associated with GLP - 1 RA therapy. The investigators are piloting…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18-60
* Recently prescribed a GLP-1RA (within one week of prescription)
* Fluent in English
* Willing to complete the study protocol
Exclusion Criteria:
* Children and adults \> 60 years of age
* Those not taking a GLP-1RA
* Those who have been on a GLP-1RA longe…
Contacts
No contact information available.